GL1X · GenesisL1 explorer

MolNFT v2 · #12826 · protein

Crystal Structure of Human Coagulation Factor XA Complexed with FXV673

1KSN: “Crystal Structure of Human Coagulation Factor XA Complexed with FXV673”. X-ray diffraction at 2.1, 2 ligands (FXV, CA), 2 pockets (best druggability 0.46). MolNFT v2 #12826 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
1KSN
Type
protein
Length
286 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.1
Source
Homo sapiens
Molecule
Coagulation factor xa
EC
3.4.21.6
UniProt
P00742
Ligands
FXV, CA
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · resolution 2.1 · 2 distinct chains · 13% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor xa (EC 3.4.21.6)protein23413% helix, 37% strandP00742
BCoagulation factor xa (EC 3.4.21.6)protein5213% helix, 27% strandP00742

Ligands and binding sites

  • FXV · Methyl-3-(4'-N-oxopyridylphenoyl)-3-methyl-2-(M-amidinobenzyl)-propionate · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11510.460.7626empty
21090.460.7926FXV

Interfaces

1 interface between chains.

  • A–B · 905 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 1KSN · Crystal structure of human coagulation factor xa complexed with FXV673 · the same entry in another collection · chain A against A, TM-score 1.00
  • P00742 · AlphaFold monomer V2.0 prediction for coagulation factor X (P00742) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.